Acute management

A Japanese paper describing the use of CCTA to support Kawasaki Disease diagnosis.

Predictors of intravenous immunoglobulin-resistant Kawasaki disease

Every clinician needs a high index of suspicion. This paper contains new information to enhance it.

‘When you hear hoofbeats, think of horses not zebras’ – the old adage is well-known to GPs but what should you do when faced with a zebra, not a horse?

Incomplete Kawasaki Disease in the Neonate – Case report of Kawasaki Disease in a 15 DAY old boy.

This paper looks at scoring methods to predict responses to IVIG therapy in a Caucasian population

Diagnosis and management of Kawasaki Disease in developing countries

This study suggests that corticosteroids combined with IVIG as initial therapy for KD showed a more protective effect against CAA, compared with conventional IVIG therapy, and the efficacy was more pronounced in the high-risk patient group.

A discussion paper on Kawasaki Disease which concludes that many aspects of KD remain unknown, although there is growing knowledge on the etiology

AHA 2017 recommendations provide updated and best evidence-based guidance to healthcare providers who diagnose and manage Kawasaki disease, but clinical decision making should be individualized to specific patient circumstances.